...

SGT-151

$150.00$1,800.00

Available!!

Fast Delivery

Discrete Shipping

Track & Trace

Secured Payment

SGT-151

SGT-151

SGT-151 is a new legal cannabinoid in all European countries also called CUMYL-PeGaCLONE.

PHARMACOLOGY OF SGT-151

Synthetic cannabinoids (SCs) are novel psychoactive substances that mimic the effects of cannabis [1–3]. These products were sold via online shops and consisted of herbal mixtures sprayed with SCs [3]. Since then, a deluge of chemical variations of SCs has been occurring worldwide due to their synthesis in clandestine laboratories, often based on pharmaceutical research and patents, posing a growing challenge for authorities regarding regulation of these substances [1,3]. More recently, several highly potent compounds have emerged on the drug market, synthesised as stated in the patent application of Bowden and Williamson (“SGT-compounds”). These drugs are characterised by a cumyl substituent, which is attached to an indole, indazole or azaindole structure. One of the first cumyl-derivatives, CUMYL-PEGACLONE, was found in 2016 on the German drug market, being sold under the street name SGT-151 [1,2]. The present study aims to understand what is inside of a SGT-151 package sold in the internet as a ‘research chemical.

The cannabinoid identification was based on its mass spectra using the Cayman database (Chemical C. Cayman Spectral Library, vol. v08302018). GC/MS was the technique used to analyse the compound using a MEGA–5 MS capillary column (0.25 µm, 0.32 mm, 30m). Chromatographic analysis was carried out under the following conditions: injection volume 1 µL and splitless injection at 280 °c. The initial oven temperature was 100 °C for 3 min, ramped to 310 °C at a rate of 30 °C/min and held at 310 °C for 10 min. The MS conditions were as follows: ionisation energy was set at 70 eV; acquisition was carried out in a scan mode range of m/z 30–450. Helium was used as the carrier gas. For purification, a HPLC/DAD, operated by Clarity software, was used with a reversed-phase column. The mobile phase was a solvent gradient system consisting of (A) 5% 10 mM ammonia format and (B) 95% acetonitrile, optimised to achieve the best resolution. The results were recorded at λ = 252 nm.

SGT-151 is similar in many ways to 5F-ADB. However, it has a much higher affinity for the CB1 receptor, at least in in-vitro studies. It is based on the typical JWH-018 four substructure template. Though chemically (and legally) it is distinct as both the ring and the bridge are in the same substructure. 

Reviews

There are no reviews yet.

Be the first to review “SGT-151”

Your email address will not be published. Required fields are marked *

CALI-BUDS-SHOP
Shopping Cart

You cannot copy content of this page

Open chat
Scan the code
Hello 👋
Can we help you?